AUSTIN, Texas, March 4, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that members from its executive leadership...
Read More Details
Finally We wish PressBee provided you with enough information of ( Genprex to Participate at BIO Europe Spring 2025 )
Also on site :